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The major surface immunoglobulins  (Igs)  on human and murine B lympho- 
cytes are IgM and IgD (1-6). Small populations of B cells also bear IgG (7, 8) or 
IgA (9).  A  large proportion of B cells express more than one isotype on their 
surface (3, 4, 6, 10, 11-13).  In this regard, we have recently demonstrated that 
neonatal murine B cells bear only IgM (14, 15); that cells later acquire IgD and 
that they subsequently greatly reduce or completely lose their surface IgM (15). 
The present studies were aimed  at establishing the role of B  cells bearing 
different receptor isotypes in generating an immune response. In these experi- 
ments,  the ability  of B  cells,  depleted of subpopulations bearing different Ig 
isotypes,  to  transfer  a  primary  response  to the  hapten,  2,4,6-trinitrophenyl 
(TNP), 1 and a  secondary response to the carrier,  sheep erythrocytes  (SRBC), 
was evaluated. 
Materials and Methods 
General Experimental Plan (Fig. 1).  Spleen cells from mice primed with SRBC were treated in 
vitro  with  complement  (C')  and  either  anti-p,  anti-7,  anti-p  plus  anti-7,  anti-K,  anti-Ig,  or 
medium (control) under conditions which specifically killed a maximum number of cells. Graded 
numbers  of cells were then injected into syngeneic, lethally irradiated,  carrier (SRBC) primed 
recipients. Animals treated in this way had radioresistant helper T cells, but no functional B cells 
(16)  so that plaque-forming cell  (PFC) responses measured should be a function of  the injected  B 
cells  only.  The recipient  animals were challenged with  heavily haptenated TNP-SRBC  and 5  days 
later  spleens were removed and assessed for  a primary IgM response to  TNP and secondary IgM 
and IgG responses to SRBC. This experimental design made it possible  to assess  the effect  of 
depleting cells  bearing Ig, IgM, or  IgG from the same primed spleen population on both primary 
and secondary responses in single  recipients. 
Animals.  (C57BL/6 × DBA/2)FI mice (BDFI) (The  Jackson Laboratories,  Bar Harbor, Maine), 
6-10 wk of  age  were  primed by  an intravenous injection  of  200/~l  of  a 10% suspension  of  SRBC 2-20 
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$ These studies  were done in partial  fulfillment  for the degree of  Doctor of  Philosophy in the 
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Abbreviations used in this  paper: BSS, balanced salt  solution;  GARIg, goat anti-rabbit  IgG; 
HRBC, horse erythrocytes;  NP40, Nonidet P40; PBS, phosphate-buffered saline;  PFC, plaque- 
forming cell(s);  RAMIg, rabbit anti-mouee Ig;  RA  T, rabbit  anti-mouse-T; RAK, rabbit anti-mouse- 
K;  RAp, rabbit  anti-mouse-/~;  SDS-PAGE, sodium dodecyl sulfate  polyacrylamide gels;  TNP, 2,4,6- 
trinitrophenyl. 
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FIG. 1.  Experimental protocol. 
wk before the spleens were removed and used as donor cells. Syngeneic recipients were injected 
intravenously with 200  ftl of a  0.01% suspension of SRBC  4-8 days before lethal X  irradiation 
(1,000 R, 13~Cs source given 4 h before reconstitution). This low dose priming of recipient animals 
assured that an excess of carrier-specific, thymus-derived, radioresistant helper cells were present 
(17). 
Antigen and PFC Assay.  The recipients were challenged intraperitoneally with 200 /El of a 
10% suspension of heavily substituted TNP-SRBC (18) the day after reconstitution and sacrificed 5 
days later.  The spleens were teased, washed once, and resuspended in 5-10 ml of balanced salt 
solution  (BSS).  The  cells  were  assayed  for direct  PFC  to  SRRC  and TNP-horse  erythrocytes 
(HRBC) using a  slide modification of the assay described by Jerne and Nerdin (19).  Indirect PFC 
were  determined  after developing the  slides further by incubation with rabbit anti-monse Ig 
(Cappel Labs, Dowingtown, Pa.), at a dilution of 1/200 with additional C' (guinea pig C', Pel-Freez 
Bio-Animals, Inc., Rogers, Ark.). 
Antisera 
RABBIT ANTI-MOUSE Ig (RAMIg) (20).  RAMIg contained antibodies specific  for  mouse ~-,  T-, a-, 
K-,  and h-chains and was a pool  of  sera  from rabbits  immunized with  a variety  of  purified  myeloma 
proteins. 
RABBIT A~rrz-MOUSE-K (R~) SERUM.  RAK serum was prepared against free light  chains ob- 
tained from reduced and alkylated TEPC-15 (a, g). The serum reacted with serum Ig and kappa- 
containing, but not lambda-containing,  myeloma proteins. 
RABBXT ANTI-MOUSE-~ (RA~) (20)  SERUM.  RA/~ serum was prepared by immunizing a rabbit 
with/z-chains isolated  from MOPC-104E. 
RABBIT ANTI-MOUSE-7 (RAT).  Normal mouse serum (Pel-Freez  Bio-Animals,  Inc.)  was brought DOROTHY  YUAN,  ELLEN  S.  VITETTA,  AND  JOHN  R.  KETTMAN  1423 
to 50% saturation with (NH4)2SO4. The resultant precipitate was centrifuged, dissolved in distilled 
water, and desalted by dialysis against H20. The IgG fraction was prepared on DEAE-Sephadex 
AS0 using 0.05 M phosphate buffer, pH 7.8. The IgG was desalted, lyophilized, and dissolved in 0.2 
M Tris,  pH 8.0,  at 10 mg/ml.  The T-chains were prepared by reduction of the IgG with 20 mM 
dithiothreotol and alkylation with 40 mM recrystallized  iedoacetamide.  Preparations were di- 
alyzed against 1 M  propionic acid and the T-chain fraction was prepared by gel filtration on a 
G100 Sephadex column equilibrated with I M propionic acid. The heavy chain fraction was pooled, 
concentrated, and rechromatographed. Aliquots containing 50/~g of the T-chain were frozen and 
stored at -20°C. The purity of the fraction was determined by electrophoresing 50/~g of purified 
material on sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) followed by staining the gel. 
In  addition,  20 fig  of  the  purified  gamma chain was radioiodinated  and i × 106  cpm of  the labeled 
protein analyzed by SDS-PAGE.  Greater than 95% of the radioactivity  migrated as T-chain. 
Rabbits were injected  subcutaneously  and  intramuscularly at  1-  to  2-too  intervals  with  50/~g  of  T- 
chain in Freund's complete adjuvant (Grand Island  Biological  Co.,  Grand Island,  N. Y.). 
GOAT  ANTI-RABBIT IgG  (GARIg) (20)  ANTISERUM.  GARIg  antiserum  contained  antibodies 
against rabbit T and L chain. All sera were evaluated by immunoprecipitation of both radioiodi- 
nated purified immunoglobulins and immunoglobulins in lysates of radioiodinated spleen cells. 
Radioimmunoassay 
PUmFXED MYELOMA PROTmN.  Purified IgM from MOPC-104E,  IgA from TEPC-15,  and serum 
IgG were enzymatically iodinated with 12sI (21)  and dialyzed against phosphate-buffered saline 
(PBS), pH 7.3. Immediately before use, samples were centrifuged at 10,000 g  for 30 rain and acid- 
precipitable  radioactivity  determined.  100,000  cpm of each protein,  representing  1-6  ftg were 
diluted in 1.0 ml of PBS. 50/~1 of rabbit anti-serum against Ig, ft, or T was added and incubated for 
15  rain  at  37°C.  Complexes  were  precipitated  by  the  addition  of a  slight  excess  of  GARIg. 
Precipitates were centrifuged, washed twice in PBS, transferred to fresh tubes, and counted on a 
Beckman 300 gamma counter (Beckman Instruments, Inc., Fullerton, Calif.). 
SPLEEN CELL SURFACE Ig.  5 X 107  splenocytes  from adult  A/J mice (The Jackson Laboratory) 
were radioiodinated  (22),  lysed  in 0.5% Nonidet P40 (NP40) (Gallard-Schlesinger  Chemical Mfg. 
Corp., Long Island,  N. Y.),  and lysates  supplemented with fetal  calf  serum (GIBCO) to a final 
concentration  of  5%. Lysates  were dialyzed  for  1-16  h at  4°C  against  PBS and  centrifuged  at  10,000 
g for  30  rain.  Protein-associated  radioactivity  was  determined  in  5% trichloracetic  acid  (22).  Equal 
aliquots  of  the  lysate  were  treated  with  saturating  amounts (50  ~l)  of  either  anti-  ft,  anti-T,  anti-Ig, 
or anti-K.  Complexes were absorbed to fixed  Staphylococcus aureus (Cowan-I strain)  (23),  pel- 
leted, washed, and the complexes eluted from the bacteria in 1% SDS, 8 M  urea, 0.1 M  2- 
mercaptoethanol, pH 8.4,  by boiling  for  1-2  rain.  The eluate  was electrophoresed  for  16  h at  4 mA 
on 7.5% SDS-PAGE  with internal  markers consisting  of  3H-/~  and 3H-L chains (14).  Gels were 
fractionated  and radioactivity  determined by double-label  counting. 
C'-Mediatcd Cytolysis  by Specifw Anti-Igs.  Donor cells  were washed twice in BSS and were 
resuspended in Eagle's  minimal essential  medium (MEM) (GIBCO) supplemented with 5% fetal 
calf  serum and nonessential amino acids.  Suspensions were incubated with optimal amounts of 
either  heat-inactivated  RAMIg, RAK, or  RA  T at  4°C in  the presence of  0.01  M  sodium azide  (final 
concentration)  for I h. The cells  were then pelleted  and resuspended at 4 × 107/mI  in medium 
containing 20%  rabbit  C' (Pel-Freez  Bio-Animals, Inc.)  and  azide.  Cells  were incubated at  37°C for 
35 rain.  Incubation of  cells  with anti-imrnunoglobulin serum caused capping even at 4°C,  which 
protected  the  cells  from  C'-mediated  cytolysis.  The  addition  of  sodium  azide  to  the  cell  suspensions 
increased  the efficiency  of  the specific  lysis,  presumably by preventing the capping. When killing 
with RA~ was performed, a one-step  procedure was utilized  where the antiserum was incubated 
with  the cells,  azide,  and C' at  37°C for  35 rain.  This was necessary since  the RA~t serum did  not 
kill  effectively  in  a two-step  procedure.  Treatment  with  anti-/~  plus  anti-T  was  performed  in  a two- 
step  procedure, using anti--/plus  azide  followed  by anti-~,  azide,  and C'. 
Determination of Surface Ig Isotype of Cells Remaining  after C'-Mediated Cytolysis.  5  ×  107 
splenocytes from adult BDF~  mice were radioiodinated (22) and washed once in PBS and once in 
MEM containing 5% fetal calf serum. The cells were subsequently treated with specific antisera 
and C' as described in the previous section. After washing once, the cells were fractionated On a 1 g 
fetal calf serum gradient to remove dead cells (20).  The fractions from the gradient containing 
greater than 98% small cells with greater than 95% viability were lysed in 0.5% NP40. The lysates 1424  CELL  SURFACE  Ig.  XX 
TABLE  I 
Immunoprecipitation of Radioiodinated Myeloma Proteins  with 
Monospecific Antisera* 
Rabbit antiserum 
Myeloma proteins* 
IgG (7,  K)  IgM (~, X)  IgA (a, K) 
cpm immunoprecipitated 
Anti-Ig§  87,630  91,340  87,829 
Anti-~  4,023  93,662  3,764 
Anti-~  91,828  3,786  2,858 
Anti-&x (control)  3,890  4,285  3,163 
* Myeloma proteins which were >95% acid precipitable were dissolved in 1.0 
ml PBS and centrifuged at 10,000 g for 30 min. A saturating amount of rabbit 
antiserum and a slight excess of GARIg were added. The precipitates were 
centrifuged, washed, and counted. Aliquots of each were further assessed by 
SDS-PAGE. 
* 100,000 cpm (1-6 ~g) of each protein was used in the assay. 
§ This antiserum contained antibodies against  ~, 7, K, and ~-chains. 
were  dialyzed  overnight and  immunoprecipitated  with  RAMIg as  described  in  the  preceding 
section. 
Results 
Specificity of the Antisera Used in C'-Mediated Cytolysis.  The monospecific- 
ity of each of the antisera used for selective killing of B-cell subpopulations was 
tested by immunoprecipitation of 125I-labeled myeloma proteins. Table I shows 
that under saturating conditions of antiserum, 87-93% of the total radioactivity 
associated  with  each  myeloma protein  was  bound  only  by  the  appropriate 
antiserum. 
To show that the antisera were also specific for normal murine splenic surface 
Igs, spleen cells were radioiodinated, lysed, and immunoprecipitated with each 
antiserum, using fixed S. aureus  to bind the immune complexes. The PAGE 
patterns in Fig. 2 show that RAMIg serum precipitated both IgM and IgD from 
lysates of spleen cells by virtue of its activity against L chains, whereas RA~ 
serum precipitated only IgM from another aliquot of the same lysate. IgG was 
not detected on enzymatically iodinated lymphocytes in confirmation of  previous 
reports (14, 24, 25). Presumably, it is present in quantities too low for detection 
by this assay.  When the same sera were tested for cytotoxic activity against 
spleen cells, the net cytotoxicities using RAMIg, RAK, RAft, and RA  T were 54, 
48, 42, and 0 --* 15%, respectively. 
Effect of Eliminating B-Cell Subpopulations from "Long-Term" Primed Do- 
nors.  Cells from animals immunized 12-20 wk previously (long-term primed) 
with a  high dose of SRBC were treated with either RAMIg, RAft, RA  T, or an 
equivalent volume of culture medium in the presence of  rabbit C'. The cells were 
centrifuged, resuspended in medium, and injected intravenously into lethally 
irradiated,  carrier-primed,  syngeneic recipients.  The  number of PFC  in the 
spleen of each of the recipients was determined 5 days after antigenic challenge 
with heavily substituted  TNP-SRBC.  Since the injected cells  were prepared 
from spleens of animals which had not been previously exposed to the hapten DOROTHY  YUAN,  ELLEN  S. 
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Fro. 2.  SDS-PAGE  analysis of cell  surface Ig precipitated by RAMIg,  RA/~, or RA  T. 
Separate aliquots  of  the lysate  from radioiodinated spleen cells  were incubated with either 
RAMIg, RAp, or RAT and complexes were absorbed to  S. aureus. The immune complexes 
were then eluted from S. aureus in SDS-urea, reduced, and electrophoresed on 7.5% SDS- 
PAGE  for 16 h at 4 mA/gel. Gel profiles  were plotted such that SH-~ chain markers 
(fractions  15-20) were aligned for all three gels.  Similar analysis of immunoprecipitates 
using RAK revealed a pattern identical  to that of  the RAMIg precipitate. 
TNP, the PFC response assayed against TNP-HRBC represents a primary B-cell 
response against  TNP,  whereas  PFC against  SRBC are derived mainly from 
memory B cells. No indirect PFC were observed with TNP-HRBC at the time 
chosen for assay. 
Fig.  3  shows  the  results  of such  a  depletion  experiment.  The  direct  and 
indirect PFC responses of animals which received spleen cells treated with RA~ 
and C' are presented together with the responses of two types of control animals: 
those which received cells treated with C' alone and those which received cells 
treated with RAMIg plus C'.  It can be seen that the PFC response is linearly 
related to the number of live cells injected and that carrier-primed,  irradiated 
animals which were not reconstituted gave less than 100 PFC/spleen, indicating 
complete dependence of the response on the donor cells. Treatment with RA/~ in 
the presence of C' reduced the response to TNP by more than 99% as compared to 
the  C'  control,  indicating  that  cells  bearing  IgM  (with  or  without  another 
isotype) are responsible for the primary  (anti-TNP) response.  In contrast,  nei- 
ther the direct nor the indirect  (IgG) anti-SRBC PFC responses were reduced. 
Indeed,  an apparent  enrichment  of approximately twofold for these responses 
was observed.  This  apparent  enrichment  is  due to the  manner  in  which the 
results are displayed, i.e., the response is plotted as a function of the remaining 
live cells injected.  [If the size of the response was plotted as a  function of the 
initial number of cells to be transferred (regardless of the number subsequently 
killed),  the slopes of the anti-SRBC PFC in the C' control and anti-/~ plus C' 
group  would be approximately  equal.]  Elimination  of cells bearing  IgG with 
RAy and C' (Fig. 4) reduced the indirect PFC response to SRBC to less than 15% 
of the C' control, whereas neither the primary IgM (anti-TNP) nor the second- 10.0 
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FIG. 3.  PFC responses of lethally  irradiated animals reconstituted with SRBC-primed 
spleen cells  depleted of  IgM-bearing cells.  Recipient animals were injected  with 200/~l of 
spleen cells  previously  treated with either  RAMIg and C' (A),  RA/z and C' (O),  or C' alone 
(e). Reconstituted mice were challenged with TNP-SRBC  on the following day. PFC 
responses per spleen against TNP-HRBC  and SRBC  assayed 5 days after challenge are 
shown in  the  vertical  axis.  Each point  represents  the  response of  one  recipient.  The number 
of  viable cells  injected  represents a different  percentage of  the original  spleen cell  popula- 
tion  since  each antiserum had a different  net cytotoxicity. 
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FIG. 4.  PFC responses of lethally  irradiated animals reconstituted with SRBC-primed 
spleen cells  depleted of  IgG-bearing cells.  Recipient animals were injected  with 200 /~l  of 
spleen cells  treated  previously with either  RAMIg and C' (A),  RA  T and C' (O),  or C' alone 
(e). Reconstituted mice were challenged  with TNP-SRBC  on the following day. PFC 
responses per spleen against TNP-HRBC  and SRBC  assayed 5 days after  challenge are 
shown in the vertical  axis.  See legend for Fig. 3 for  further details. 
ary IgM (anti-SRBC) response was significantly reduced. As seen in Fig. 4, the 
effect of killing by RAT on the IgG response was not as complete as the effect of 
RA~ killing (Fig. 3) on the primary IgM response. It is possible that the number 
of IgG molecules on  some of the  memory cells  is  too low for RA-/-mediated 
killing. Alternatively, a portion of  the IgG response may arise from cells bearing 
other isotypes. In both experiments, the responses of animals adoptively trans- DOROTHY  YUAN,  ELLEN  S.  VITETTA,  AND  JOHN  R.  KETTMAN  1427 
ferred with cells treated with RAMIg serum and C' were reduced by at least 87% 
(Figs.  3 and 4). 
Although cells giving rise to the secondary IgM response could not be elimi- 
nated by  either RAtz  or  RA~/, they could be  deleted by RAMIg.  Such cells 
therefore bear amounts of Ig which are sufficient for C'-mediated lysis using a 
polyvalent reagent. It is possible that such cells bear both IgM and IgG but not 
in sufficient density to be lysed by either anti-tz or anti~y and C'. Therefore, a 
combination of RA~ plus RA~/and C' might eliminate these cells. Primed donor 
cells were therefore first incubated with RA~  (in azide),  washed, and subse- 
quently incubated with RAtz and C' (in azide). Table II indicates that all three 
responses, including the secondary IgM response can be eliminated by such a 
procedure. Furthermore, prior absorption of either the anti-~ or anti~ serum 
with their corresponding isotype (IgM or IgG) abrogated their ability to elimi- 
nate these responses (Table II), indicating that the effect of these antisera is due 
to their anti-Ig specificities. The effect of treatment by RA~ plus RA~ plus C' on 
the deletion of the secondary response was not as complete as when RAMIg or 
RAK were used (Table II). These experiments suggest that cells giving rise to the 
secondary  IgM response bear low levels of  both IgM and IgG on their surface. 
The depletion experiments using each of the three specific  antiserum were 
performed three to six times (Table II). In depletion experiments involving RA~ 
or RA~/, enhancement of the PFC responses of the surviving subpopulation was 
sometimes observed.  In  control experiments, where cells  were treated with 
antisera plus heat-inactivated C'  before adoptive transfer, we have also ob- 
served sporadic enhancement of the PFC  response. The explanation for this 
finding is not clear. Table III summarizes the results of our depletion experi- 
ments and suggests that the long-term memory cells giving rise to the primary 
and secondary adoptive responses each bear different isotypes. 
Effect of Varying the Interval between Priming and Selective Cytolysis on the 
Ability  to Deplete  Specific  Subpopulations.  In  order to  determine whether 
susceptibility of the various B-cell  subpopulations to killing by specific anti- 
immunoglobulin sera and C' changes with time after immunization, we recon- 
stituted irradiated hosts with cells from donor animals primed 2-8 wk previ- 
ously. 
Results shown in Fig. 5 indicate the effect of treating cells from donors primed 
for various periods of time with either RA~ or RAy on their ability to respond to 
a challenge with TNP-SRBC. After elimination of the IgG-bearing subpopula- 
tion by RA~/plus C', the effect on each of the three responses was constant. On 
the other hand, elimination of IgM-bearing cells from donor spleens removed 
shortly after primary immunization, resulted in considerable inhibition (more 
than 75%) of the secondary IgM anti-SRBC PFC response, although the effect on 
the IgG anti-SRBC PFC response remained minimal and the inhibition of the 
anti-TNP primary response also remained constant. 
The decreasing susceptibility to killing by RA~ and C' of the cells giving rise 
to the secondary IgM response suggests that the number of IgM molecules on 
this population of cells decreases with time after immunization. 
Examination of Surface Isotypes on Cells Surviving Treatment with Antibody 
Plus  C'.  A  subpopulation  of cells bearing large  amounts of IgD  has  been 1428  CELL  SURFACE  Ig.  XX 
TABLE  II 
Inhibition of PFC Responses of Cells from Long-Term  Primed Animals by Treatment 
with Specific Rabbit Anti-Immunoglobulins and C'* 
Antiserum  Exp. no. 
Percent inhibition* 
TNP-HRBC  SRBC  IgM  SRBC  IgG  IgM 
RAMIg  1§  97.9  87.2  95.7 
2 II  99.3  98.7  97.7 
3  98.0  98.1  96.8 
Average  98.4  94.7  96.7 
RAK  1  94.8  96.2  96.6 
2  97.2  97.9  97.8 
Average  96.0  97.0  97.2 
RAp  1§  98.9  -28.0¶  0.1 
2  80.6  2.9  -56.8 
3  88.4  13.3  -0.8 
Average  89.3  - 3.9  -  19.2 
RAT  1 I]  23.4  25.3  85.0 
2  -48.3  -43.0  46.4 
3  -49.6  19.3  50.1 
4  10.4  -9.1  79.9 
5  -19.0  15.3  84.2 
6  19.1  0.5  70.3 
Average  -  10.6  1.4  69.3 
RAp +  RAT  1  96.8  86.8  85.0 
2  99.0  89.9  96.5 
3  92.7  72.2  49.2 
4  92.9  82.7  87.6 
Average  95.4  82.9  79.6 
RAp +  RAT (absorbed)**  1  -28.4  6.7  29.7 
* Cells were obtained from donor mice 3-4 mo after primary immunization. 
Average iAv.) PFC response of cells treated-with C' only-[(Av. PFC response of same num- 
ber of cells treated with antiserum  +  C')/(Av. PFC response of cells treated with C')]  x  100. 
§ Data plotted in Fig. 3. 
II Data plotted in Fig. 4. 
¶ Negative values indicate enhancement. 
** RAp serum absorbed with IgM from MOPC-104E. RA  T serum absorbed with IgG from normal 
mouse serum prepared as described in Materials and Methods. 
observed  in  our  previous  experiments.  Thus,  RAft  plus  C'-mediated  killing  of 
radioiodinated  A/J  spleen  cells left a  residual  population  in which  only  surface 
IgD  was  detected  (13).  A  similar  experiment  using  normal  BDFI  spleen  cells 
indicates  that  the same  subpopulation  is present  in this strain.  As shown  in Fig. DOROTHY  YUAN,  ELLEN  S.  VITETTA,  AND  JOHN  R. 
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Response 
% of  response accounted for  by cells  bearing: 
IgM*  IgG*  IgM + IgG$  Other§ 
Primary IgM  89  0  6  3 
Secondary IgM  0  1  82  12 
Secondary IgG  0  69  I0  17 
* Average value from Table II.  The negative values are expressed as 0. 
¢ Average value from Table II for deletion  with anti-p plus anti-7 minus 
individual  values obtained with anti.p and anti-  T. All negative values are 
expressed as 0 in  the calculations. 
§ Average value from Table II for  deletion  with anti-lg  minus average value 
obtained with  anti-p  plus  anti--/.  This  difference  could  reflect  a difference  in 
efficiency  of  killing  between anti-L and anti-H chain. However, it  could  be 
due to cells  bearing  8 only,  8 plus  7, or p plus 8. 
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FIG.  5.  The effect of time elapsed after primary immunization on the ability of RAp and 
RA  T plus C' to kill subpopulations of cells giving rise to the primary, secondary IgM, and 
secondary  IgG responses.  Cells  from animals primed 2-12 wk earlier with SRBC were 
treated with either RAp plus C', RAT plus C', or medium plus C', and adoptively trans- 
ferred to recipients as described in Materials and Methods. The percent inhibition at each 
time point was calculated  as described  in Table II. Inhibition by RAp plus C'  (-O-). 
Inhibition by RA? plus C' ( -~ ). The lines drawn were determined from linear regression 
analysis of each set of points.  All slopes with one exception are not significantly different 
from zero as determined by an F test in an analysis of variance (P > 0.1 top > 0.25). The 
slope obtained for inhibition by RAp of the secondary IgM SRBC response  (middle panel) 
was found to be significantly different from zero (P < 0.01) and has an associated correlation 
coefficient of -0.91. 
6A,  elimination  of cells  bearing  IgM  with  RA/~  and  C'  reduced  by  73%  the 
amount  of radioiodinated  IgD  in  the  lysate  of  the  remaining  viable  cells, 
indicating that the majority of these cells bear both IgD and IgM. However, 27% 
of the IgD is present on cells which express too little IgM to be killed with anti-/~ 
plus C'. Fig. 6 B indicates that elimination of cells bearing IgG with RA? and C' 
does not affect the amount of either IgM or IgD in the lysate of the remaining 
cells indicating that, in contrast to cells bearing both IgM and IgD, there are few 
cells bearing  both  IgG and  IgD  or  IgG and  IgM.  Furthermore,  treatment  of 
spleen cells with a  combination of IgG and IgM in the presence of C' does not 
affect the  amount  of IgD  detectable  in  the  lysate  of the  remaining  cells,  as 1430 
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FIG.  6.  Surface Ig on radioiodinated small lymphocytes after elimination of cells bearing 
(A) IgM,  (B) IgG, and (C) IgM plus IgG. In these experiments, labeled cells were treated 
with antibody plus C' or C' alone, the dead cells were eliminated on a  lg gradient, and the 
Ig remaining on the small,  viable cells examined after lysis,  immunoprecipitation,  and 
SDS-PAGE of the immunoprecipitate. The patterns in panel C represent cells treated with 
anti-/~  plus C' vs. cells  treated with anti-~ plus anti-T  plus C'. In comparing patterns from 
different  gels,  the L chains were aligned. 
compared to cells which survive treatment with RA/~ and C'  (Fig. 6 C). Thus, 
either the IgM-IgG-bearing cells, which give rise to the secondary IgM response, 
bear little or no IgD on their surface or they are present in numbers too low for 
detection of their surface IgD by iodination. 
Discussion 
The present experiments provide further evidence that subpopulations of B 
lymphocytes bearing different surface Igs perform different functions. Thus, 
treatment of spleen cells from SRBC-primed mice with anti-Ig plus C' abolished 
the capacity of these cells to adoptively transfer an IgM-  or IgG-memory re- 
sponse to SRBC and a primary response to TNP, indicating that the function of 
Ig-bearing cells only (and not Ig- progenitor cells)  is being measured in the 
experimental system employed. When cells from mice primed 3-4  mo earlier 
were treated with anti-/~ plus C', the adoptive primary IgM (anti-TNP) response 
was completely eliminated, whereas neither the secondary IgM nor IgG (anti- 
SRBC) responses were affected. These experiments suggest that cells giving rise 
to the primary IgM response bear IgM.  Such results are in agreement with 
previous reports  which demonstrated that the in  vitro  and in vivo primary DOROTHY  YUAN,  ELLEN  S.  VITETTA,  AND  JOHN  R.  KETTMAN  1431 
responses to a variety of antigens could be eliminated by treatment with anti-ft 
(26, 27) or could be positively selected with anti-ft using the cell sorter (28). In 
addition, the polyclonal IgM response to the B-cell mitogen, lipopolysaccharide, 
could be eliminated by anti-ft plus C' (20) or blocked by anti-ft in vitro (29, 30). 
To our knowledge, however, this is the first demonstration that cells giving rise 
to the secondary IgM response cannot be depleted by anti-ft plus C'. Such cells 
could, however, be eliminated by a combined treatment with RAft and RA  T plus 
C'.  These results  suggest that  the majority of cells from long-term primed 
animals, which give rise to a  secondary IgM response, bear small amounts of 
both IgM and IgG on their surface. Apparently anti-serum directed against only 
one heavy chain isotype was not sufficient to achieve C'-dependent lysis of these 
cells. A correlation between the extent of C'-mediated lysis and the density of H- 
2 antigens on cell surfaces has been demonstrated in a number of myeloma and 
lymphoma cell lines (31). 
It should be emphasized that a general limitation of the deletion approach is 
the inability to interpret definitively the failure to kill. In the present experi- 
ments, the failure probably results from a low concentration of Ig. It should also 
be stressed that anti-K probably is more effective in binding surface Ig on cells 
bearing a particular isotype than the corresponding anti-H chain serum (32, 33). 
Thus, differences between the numbers of cells killed by anti-K and an anti-H 
chain sera can be  due either to the above reason or to a  second population 
bearing another isotype. 
In contrast to the above results, treatment of cells obtained from animals 
primed for relatively short periods of  time with only RAft and C' was effective  in 
eliminating their ability to transfer a  secondary IgM response.  This finding 
suggests that shortly after priming, IgM memory cells still bear relatively large 
amounts of IgM.  As the interval between priming and adoptive transfer in- 
creases, the concentration of surface IgM decreases. 
Indeed, previous work by Pierce et al. (34), Kishimoto and Ishizaka (35), and 
Strober (36) using cells derived from mice primed less than 1 mo previously have 
shown  that  IgM  memory is  carried by  IgM-bearing lymphocytes. Further, 
Strober has reported that IgM-bearing precursors found after short-term prim- 
ing subsequently decreased in number. A less likely, but plausible, possibility is 
that a  fraction of the memory cells present after short-term priming may be 
IgM-bearing plasmablasts which increase their rate of secretion and perhaps 
even switch to IgG after further contact with antigen. Such cells might disap- 
pear several months after priming. It was not possible  to determine the exact 
time that IgG is acquired by the precursors of the IgM secondary response since 
anti-ft plus C' deleted the entire response and anti-  T plus C' alone was ineffec- 
tive when the interval between priming and transfer was short. 
We have also shown, by antibody-mediated killing of radioiodinated lympho- 
cytes, that although the majority of the cells eliminated by RAft plus C' bear 
IgD, the cells eliminated by a combination of RAft and RAT plus C' may bear no 
other isotype. We cannot, however, eliminate the possibility that the subpopula- 
tion bearing both IgM and IgG is too small to effect the amount of radioiodinated 
IgD recovered from cells surviving treatment with anti-ft plus anti-T plus C'. 
Our  experiments with  RAT  plus  C'  demonstrate that  antiserum directed 1432  CELL  SURFACE  Ig.  XX 
solely against  the  IgG heavy chain  markedly  diminishes  the  secondary IgG 
response but not the primary or secondary IgM responses.  These IgG-bearing 
memory cells are present in the spleen as early as 2 wk after primary immuniza- 
tion. These results, therefore, confirm earlier studies by Okumura et al. (37) and 
by Mason  (38),  who demonstrated that cells giving rise to memory responses 
bear surface IgG. A report by Abney et al. (39), however, indicates that clones of 
cells which elaborate IgG~ and IgG2A memory can be prohibited from binding 
antigen by treatment with anti-~, but not anti-~ (or anti-a). In studies by Pierce 
et al.  (34) inhibition of the in vitro IgG memory response with anti-~ was also 
reported. It is possible, therefore, that the predominant isotype on memory IgG 
cells is IgG but that a portion of these cells also bear small amounts of IgM. This 
possibility is supported by our finding that treatment of adoptively transferred 
cells  with  C'  and  a  combination  of anti-~  plus  anti~  eliminated  the  IgG 
response more effectively than anti~ alone. 
How can the results presented here be reconciled with the failure to demon- 
strate IgG on murine splenocytes by enzymatic iodination (14, 24, 25)? There are 
several possibilities to consider:  (a)  Surface IgG is not readily iodinated.  (b) 
Surface IgG is released before or after iodination.  (c) The number of Ig mole- 
cules per cell and/or the number of IgG-bearing cells is small.  We believe that 
the last explanation is the most likely- that there are a  small number of IgG- 
bearing cells and a low density of IgG receptors per cell- because murine IgG in 
solution  (21),  in detergent-containing  cell lysates (E.  S.  Vitetta,  unpublished 
observations),  or on plasmacytoma  cells  (40)  is readily  iodinated,  suggesting 
that surface IgG on spleen cells should not escape effective labeling. In addition, 
several reports indicate that there are only 1-10% (37) IgG-bearing lymphocytes 
in the spleen. Therefore, the iodination method may not be sufficiently sensitive 
to detect the small amount of surface IgG. 
In these studies,  we have  demonstrated  that  cells giving rise to a  primary 
adoptive IgM response are easily eliminated with anti-~ plus C' and, thus, bear 
relatively large quantities of IgM on their surface. Precursors of the secondary 
IgM response bear large quantities  of IgM if they are obtained from animals 
shortly after primary immunization.  As the interval  after primary immuniza- 
tion increases, the density of surface IgM decreases to the point, 3 or 4 mo after 
immunization,  where the cells can no longer be eliminated by anti-~ plus C'. 
These long-term memory cells may also bear very low concentrations of IgG. As 
memory  cells  become  precursors  of the  IgG  response,  the  concentration  of 
surface IgG increases such that the majority of IgG precursors can be eliminated 
by anti~ plus C'. The present experiments were not designed to define the role 
of surface IgD in the adoptive responses studied because our anti-8 serum (41) is 
not cytotoxic. Indirectly,  our results suggest that a  population of IgD-bearing 
cells, which may also express very low amounts of IgM or IgG, contributes to the 
secondary IgM and IgG responses.  Similar results have been obtained by posi- 
tive selection, in which IgD-bearing cells contribute to the primary as well as 
secondary adoptive responses to dinitrophenylated  bovine serum albumin  (41, 
42).  These  latter  studies  suggest that  IgD may be present  on  all  cells  which 
respond to thymus-dependent antigens. In vitro studies (43) support this conten- 
tion  and  further  suggest that  thymus-independent  responders  lack IgD.  The DOROTHY  YUAN,  ELLEN  S.  VITETTA,  AND  JOHN  R.  KETTMAN  1433 
possibility, therefore, that IgD is a marker for a B-cell subset that can receive T- 
cell help deserves further exploration. 
Summary 
Murine spleen cells were depleted of specific B-cell subpopulations bearing 
different immunoglobulin isotypes by means of complement-mediated cytolysis 
after treatment with antisera specific for IZ- and ~-chains. The functional effect 
of this depletion was measured by assaying both the primary and secondary 
plaque-forming cell  responses  of the  residual  cells  after transfer to  carrier- 
primed lethally irradiated hosts. The results suggest that cells bearing IgM are 
the progenitors of  plaque-forming cells in the primary response and cells bearing 
IgG are  the  major progenitors of IgG plaque-forming cells  in the  secondary 
response. The quantity of IgM on progenitors of secondary IgM plaque-forming 
cells decreases markedly as the interval between primary immunization and 
antigenic challenge increases. Long-term memory cells for the secondary IgM 
response bear small amounts of both IgM and IgG. 
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